
During the Health System Executive Summit, Candy Tsourounis, PharmD, and Elise Wozniak, PharmD got candid about the barriers and financial risk surrounding this innovative therapy.
Congress to weigh Medicare reform plan and patient safety; FDA addresses product risk and quality






